Dose Escalation and Dose Expansion Study of MDX2001
Phase 1/2
115
about 4.7 years
18+
6 sites in CO, FL, MA +2
What this study is about
This trial is testing a treatment called MDX2001 in people with advanced solid tumors. The goal is to see if the treatment is safe, well-tolerated, and helps fight cancer cells. It includes different phases to determine the best dose for further development.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take MDX2001
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: All Phases: Adverse events (AEs), Phase 1b and Phase 2a: Objective response rate of MDX2001
Secondary: All Phases: Disease control rate (DCR), All Phases: Duration of response (DOR), All Phases: Pharmacokinetic Parameter Cmax of MDX2001, All Phases: Pharmacokinetic parameter area under the curve (AUC(0-T)) of MDX2001, All Phases: Progression free survival (PFS), Phase 1a: Objective response rate of MDX2001
Oncology